🕵️ Oragenics Inc ($OGEN)
SEC insider & ownership activity, last 12 months · CIK 1174940 · every row links its SEC filing
Over the last 12 months insiders sold $198 with no open-market buying against it. Frederick W. Telling sold $198 in discretionary trades (Dec). One red-flag 8-K in the window: Delisting notice (3.01), Oct 16, 2025.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $198 (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Frederick W. Telling | 0 | – | 1 | $198 | Dec 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FIVE Narrow LANE LP | 10.0% | 13G | Jul 2, 2025 | filing ↗ | |
| Sabby Management, LLC | 9.9% | 13G | Jan 21, 2026 | filing ↗ | |
| Hal Mintz | 9.9% | 13G | Jan 21, 2026 | filing ↗ | |
| Sabby Volatility Warrant Master Fund, Ltd. | 9.9% | 13G | Jan 21, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Frederick W. Telling | $192 | Dec 12, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 18, 2026 | filing ↗ |
| Other events (8.01) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Other events (8.01) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Other events (8.01) | Apr 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 13, 2026 | filing ↗ |
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 (5.08) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Other events (8.01) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 11, 2025 | filing ↗ |
| Other events (8.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 16, 2025 | filing ↗ |
| Delisting notice (3.01) | Oct 16, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 16, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 1, 2025 | filing ↗ |
| Other events (8.01) | Aug 11, 2025 | filing ↗ |